Quick take: Pharmaniaga, Duopharma climb on vaccine hopes


FILE PHOTO: Small bottles labelled with "Vaccine" stickers seen near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

KUALA LUMPUR: Shares of drug makers Pharmaniaga and Duopharma climbed in early Monday trade as hopes for a vaccine for the Covid-19 perked up after reports of human trials could start in Singapore as early as this week.

At 9.41am, the FBM KLCI was up 0.09 point to 1,589.70. Turnover was 2.06 billion shares valued at RM1.27bil. There were 381 gainers, 340 losers and 350 counters unchanged.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

Malaysia's economy likely grew 3.9% y-o-y in Q1 - advance estimate
Oil prices surge 3% on reports of Israeli strikes on Iran
US bonds rally on reports of Middle East missile strike
Fed policymakers agree: there's no urgency to cut rates
Ringgit opens easier against US$ as Fed turns hawkish
Main Market-bound Keyfield to gain from AWB market upcycle
FBM KLCI continues rebound after two days of recovery
Trading ideas: RHB, Axiata, Yinson, Affin, Kimlun, AWC, Pansar, DC Healthcare, AwanBiru, Systech, Auro, Bursa Malaysia, HeiTech Padu, AmFirst REIT and Sin-Kung Logistics
Farhash no more HeiTech’s substantial shareholder
Trading suspension for Awanbiru

Others Also Read